The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity

Journal of Dermatological Science

Volumn 65, Issue 3, 2012, Pages 213-219

  Hanafusa, Takaaki ^a   Azukizawa, Hiroaki ^a   Matsumura, Sayaka ^a   Katayama, Ichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adverse drug reaction; Drug allergy; Immunologic tests; Immunology; In vitro tests

Indexed keywords

ANTICONVULSIVE AGENT; BROXURIDINE; CARBAMAZEPINE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; PHENYTOIN; THYMIDINE; TRITIUM; VALPROIC ACID; ZONISAMIDE;

ADULT; AGED; ARTICLE; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG SPECIFICITY; ERYTHEMA MULTIFORME; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE;

ADULT; AGED; ANTICONVULSANTS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; EOSINOPHILIA; EXANTHEMA; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, DELAYED; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 84857653351     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.12.002     Document Type: Article

References (26)

1. Roujeau J.C., Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994, 331:1272-1285.
2. Takahashi H., Tanaka M., Tanikawa A., Toyohara A., Ogo Y., Morimoto A., et al. A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus. Clin Exp Dermatol 2006, 31:33-35.
3. Nishio D., Izu K., Kabashima K., Tokura Y. T cell populations propagating in the peripheral blood of patients with drug eruptions. J Dermatol Sci 2007, 48:25-33.
4. Chung W.H., Hung S.I., Yang J.Y., Su S.C., Huang S.P., Wei C.Y., et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008, 14:1343-1350.
5. Pichler W.J., Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004, 59:809-820.
6. Martin M., Wurpts G., Ott H., Baron J.M., Erdmann S., Merk H.F., et al. In vitro detection and characterization of drug hypersensitivity using flow cytometry. Allergy 2010, 65:32-39.
7. Beeler A., Engler O., Gerber B.O., Pichler W.J. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006, 117:455-462.
8. Beeler A., Zaccaria L., Kawabata T., Gerber B.O., Pichler W.J. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy 2008, 63:181-188.
9. Tsuge I., Okumura A., Kondo Y., Itomi S., Kakami M., Kawamura M., et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007, 56:149-155.
10. Nyfeler B., Pichler W.J. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997, 27:175-181.
11. Lopez S., Torres M.J., Rodriguez-Pena R., Blanca-Lopez N., Fernandez T.D., Antunez C., et al. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins. Br J Dermatol 2009, 160:259-265.
12. Gonchoroff N.J., Katzmann J.A., Currie R.M., Evans E.L., Houck D.W., Kline B.C., et al. S-phase detection with an antibody to bromodeoxyuridine. Role of DNase pretreatment. J Immunol Methods 1986, 93:97-101.
13. Kano Y., Hirahara K., Mitsuyama Y., Takahashi R., Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 2007, 62:1439-1444.
14. Gett A.V., Hodgkin P.D. A cellular calculus for signal integration by T cells. Nat Immunol 2000, 1:239-244.
15. Hung S.I., Chung W.H., Jee S.H., Chen W.C., Chang Y.T., Lee W.R., et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006, 16:297-306.
16. Hashizume H., Takigawa M. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm Venereol 2005, 85:47-50.
17. Hashizume H., Takigawa M., Tokura Y. Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 2002, 168:5359-5368.
18. Lochmatter P., Beeler A., Kawabata T.T., Gerber B.O., Pichler W.J. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity. Allergy 2009, 64:1269-1278.
19. Zawodniak A., Lochmatter P., Yerly D., Kawabata T., Lerch M., Yawalkar N., et al. In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. Allergy 2010, 65:376-384.
20. Hari Y., Frutig-Schnyder K., Hurni M., Yawalkar N., Zanni M.P., Schnyder B., et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001, 31:1398-1408.
21. + T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics. J Invest Dermatol 1993, 101:794-799.
22. Chung W.H., Hung S.I., Hong H.S., Hsih M.S., Yang L.C., Ho H.C., et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004, 428:486.
23. Chave T.A., Mortimer N.J., Sladden M.J., Hall A.P., Hutchinson P.E. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005, 153:241-253.
24. Azukizawa H., Kosaka H., Sano S., Heath W.R., Takahashi I., Gao X.H., et al. Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 2003, 33:1879-1888.
25. Azukizawa H., Sano S., Kosaka H., Sumikawa Y., Itami S. Prevention of toxic epidermal necrolysis by regulatory T cells. Eur J Immunol 2005, 35:1722-1730.
26. Azukizawa H. Animal models of toxic epidermal necrolysis. J Dermatol 2011, 38:255-260.